These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31583707)

  • 21. Levels and values of inflammatory markers in patients with angina pectoris.
    Yip HK; Wu CJ; Hang CL; Chang HW; Yang CH; Hsieh YK; Fang CY; Fu M; Yeh KH; Chen MC
    Int Heart J; 2005 Jul; 46(4):571-81. PubMed ID: 16157948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy.
    Thurner EM; Krenn-Pilko S; Langsenlehner U; Stojakovic T; Pichler M; Gerger A; Kapp KS; Langsenlehner T
    Eur J Cancer; 2015 Mar; 51(5):610-9. PubMed ID: 25618827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results.
    Prins RC; Rademacher BL; Mongoue-Tchokote S; Alumkal JJ; Graff JN; Eilers KM; Beer TM
    Urol Oncol; 2012; 30(1):33-7. PubMed ID: 20207556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival.
    Frydenberg H; Thune I; Lofterød T; Mortensen ES; Eggen AE; Risberg T; Wist EA; Flote VG; Furberg AS; Wilsgaard T; Akslen LA; McTiernan A
    Breast Cancer Res Treat; 2016 Jan; 155(2):345-54. PubMed ID: 26740213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-sensitivity C-reactive protein, but not white blood cell count, independently predicted incident diabetes in a Japanese health screening population.
    Oda E
    Acta Diabetol; 2015 Oct; 52(5):983-90. PubMed ID: 26159115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study.
    Sollie S; Michaud DS; Sarker D; Karagiannis SN; Josephs DH; Hammar N; Santaolalla A; Walldius G; Garmo H; Holmberg L; Jungner I; Van Hemelrijck M
    BMC Cancer; 2019 Aug; 19(1):858. PubMed ID: 31464604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. White Blood Cell Count and C-Reactive Protein Independently Predicted Incident Diabetes: Yuport Medical Checkup Center Study.
    Kashima S; Inoue K; Matsumoto M; Akimoto K
    Endocr Res; 2019 Nov; 44(4):127-137. PubMed ID: 30895902
    [No Abstract]   [Full Text] [Related]  

  • 28. Markers of inflammation in relation to long-term cardiovascular mortality in patients with lower-extremity peripheral arterial disease.
    Urbonaviciene G; Frystyk J; Flyvbjerg A; Urbonavicius S; Henneberg EW; Lindholt JS
    Int J Cardiol; 2012 Oct; 160(2):89-94. PubMed ID: 21463908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysis.
    Liu ZQ; Chu L; Fang JM; Zhang X; Zhao HX; Chen YJ; Xu Q
    Asian J Androl; 2014; 16(3):467-71. PubMed ID: 24589465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between metabolic syndrome, C-reactive protein, and the risk of primary liver cancer: a large prospective study.
    Song M; Liu T; Liu H; Zhang Q; Zhang Q; Wang Y; Ma X; Cao L; Shi H
    BMC Cancer; 2022 Aug; 22(1):853. PubMed ID: 35927639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased risk of cancer death in patients with chronic heart failure with a special reference to inflammation-A report from the CHART-2 Study.
    Oikawa T; Sakata Y; Nochioka K; Miura M; Abe R; Kasahara S; Sato M; Aoyanagi H; Shiroto T; Sugimura K; Takahashi J; Miyata S; Shimokawa H;
    Int J Cardiol; 2019 Sep; 290():106-112. PubMed ID: 31104823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. hsCRP Level and the Risk of Death or Recurrent Cardiovascular Events in Patients With Myocardial Infarction: a Healthcare-Based Study.
    Carrero JJ; Andersson Franko M; Obergfell A; Gabrielsen A; Jernberg T
    J Am Heart Assoc; 2019 Jun; 8(11):e012638. PubMed ID: 31140334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-sensitivity C-reactive protein is an independent risk factor for non-vertebral fractures in women and men: The Tromsø Study.
    Dahl K; Ahmed LA; Joakimsen RM; Jørgensen L; Eggen AE; Eriksen EF; Bjørnerem Å
    Bone; 2015 Mar; 72():65-70. PubMed ID: 25460573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C-reactive protein and incident hypertension in a worksite population of Japanese men.
    Kansui Y; Matsumura K; Morinaga Y; Inoue M; Kiyohara K; Ohta Y; Goto K; Ohtsubo T; Ooboshi H; Kitazono T
    J Clin Hypertens (Greenwich); 2019 Apr; 21(4):524-532. PubMed ID: 30834690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-sectional association between exposure to particulate matter and inflammatory markers in the Japanese general population: NIPPON DATA2010.
    Michikawa T; Okamura T; Nitta H; Nishiwaki Y; Takebayashi T; Ueda K; Kadota A; Fujiyoshi A; Ohkubo T; Ueshima H; Okayama A; Miura K;
    Environ Pollut; 2016 Jun; 213():460-467. PubMed ID: 26967353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective evaluation of C-reactive protein, smoking and lung cancer death in the Third National Health and Nutrition Examination Survey.
    Bittoni MA; Focht BC; Clinton SK; Buckworth J; Harris RE
    Int J Oncol; 2015 Oct; 47(4):1537-44. PubMed ID: 26323323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory prognostic markers in clear cell renal cell carcinoma - preoperative C-reactive protein does not improve predictive accuracy.
    Bedke J; Chun FK; Merseburger A; Scharpf M; Kasprzyk K; Schilling D; Sievert KD; Stenzl A; Kruck S
    BJU Int; 2012 Dec; 110(11 Pt B):E771-7. PubMed ID: 23134582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective follow-up study of the relationship between high-sensitivity C-reactive protein and primary liver cancer.
    Siyin ST; Liu T; Li W; Yao N; Xu G; Qu J; Chen Y
    BMC Cancer; 2020 Nov; 20(1):1168. PubMed ID: 33256656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-γ-induced inflammatory markers and the risk of cancer: the Hordaland Health Study.
    Zuo H; Tell GS; Vollset SE; Ueland PM; Nygård O; Midttun Ø; Meyer K; Ulvik A; Eussen SJ
    Cancer; 2014 Nov; 120(21):3370-7. PubMed ID: 24948355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
    Siemes C; Visser LE; Coebergh JW; Splinter TA; Witteman JC; Uitterlinden AG; Hofman A; Pols HA; Stricker BH
    J Clin Oncol; 2006 Nov; 24(33):5216-22. PubMed ID: 17114654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.